Clinical Trial Update: An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine

View source ↗

Summary

An observational analysis of mortality in participants who took part in three prior galantamine studies for mild cognitive impairment; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Mild Cognitive Impairment | Status: COMPLETED